Evidence_of_malignant_features_in_histologically_mature_teratoma._A_total_of_33_specimens_from_29_patients_with_residual_stable_teratoma_and_mature_growing_teratoma_after_chemotherapy_was_analyzed_for_clinicopathological_and_deoxyribonucleic_acid_(DNA)_flow_cytometric_variables,_as_well_as_the_presence_of_proliferative_antigen_and_tumor_marker_levels_in_an_attempt_to_explain_their_clinical_behavior._We_compared_the_flow_cytometric_and_histological_data_of_these_stable_and_growing_teratomas,_and_of_nonseminomatous_germ_cell_tumors_before_chemotherapy._The_DNA_content_of_residual_teratoma_did_not_differ_significantly_from_that_of_the_primary_testicular_tumors_(1.38_versus_1.48)._Histological_analysis_of_stable_and_growing_teratomas_revealed_no_significant_difference_but_proliferative_cellular_nuclear_antigen_was_expressed_mainly_in_the_epithelial_component_of_the_growing_teratoma._alpha-Fetoprotein,_beta-human_chorionic_gonadotropin_and_carcinoembryonic_antigen_were_elevated_in_the_fluid_of_6_excised_teratomas,_while_concomitant_serum_levels_were_normal._The_aneuploidy_and_elevated_cystic_fluid_tumor_markers_confirm_the_malignant_phenotype_of_post-chemotherapy_residual_teratomas._Therefore,_complete_surgical_removal_is_essential_despite_the_benign_histological_appearance.